NCT02809144View on ClinicalTrials.gov

A Novel Combination of Peripheral Nerve Blocks for Patients Scheduled for Shoulder Surgery

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions
Pain
Interventions
PROCEDURE

Nerve block

Nerve block: 31 ml ropivacaine 7.5 mg/ml (Lateral sagittal infraclavicular brachial plexus block) + 4 ml ropivacaine 5 mg/ml (suprascapular nerve block) + 5 ml ropivacaine 5 mg/ml (superficial cervical plexus block)

Trial Locations (1)

9038

University Hospital of North Norway, Tromsø

All Listed Sponsors
lead

University Hospital of North Norway

OTHER

NCT02809144 - A Novel Combination of Peripheral Nerve Blocks for Patients Scheduled for Shoulder Surgery | Biotech Hunter | Biotech Hunter